Your browser doesn't support javascript.
loading
Ceftriaxone pharmacokinetics by new simple and sensitive ultra-high-performance liquid chromatography method.
Campos, Michel Leandro; de Moura Alonso, Juliana; Dos Santos Martins, Evelin; Oliveira, Jonata Augusto; Hussni, Carlos Alberto; Peccinini, Rosângela Gonçalves.
Afiliação
  • Campos ML; Department of Natural Active Principles and Toxicology, School of Pharmaceutical Sciences, UNESP-Univ Estadual Paulista, Araraquara, Sao Paulo, Brazil.
  • de Moura Alonso J; Department of Veterinary Surgery and Anesthesiology, School of Veterinary Medicine and Animal Science, UNESP-Univ Estadual Paulista, Botucatu, Sao Paulo, Brazil.
  • Dos Santos Martins E; Department of Natural Active Principles and Toxicology, School of Pharmaceutical Sciences, UNESP-Univ Estadual Paulista, Araraquara, Sao Paulo, Brazil.
  • Oliveira JA; Department of Natural Active Principles and Toxicology, School of Pharmaceutical Sciences, UNESP-Univ Estadual Paulista, Araraquara, Sao Paulo, Brazil.
  • Hussni CA; Department of Veterinary Surgery and Anesthesiology, School of Veterinary Medicine and Animal Science, UNESP-Univ Estadual Paulista, Botucatu, Sao Paulo, Brazil.
  • Peccinini RG; Department of Natural Active Principles and Toxicology, School of Pharmaceutical Sciences, UNESP-Univ Estadual Paulista, Araraquara, Sao Paulo, Brazil. Electronic address: peccinin@fcfar.unesp.br.
Diagn Microbiol Infect Dis ; 88(1): 95-99, 2017 May.
Article em En | MEDLINE | ID: mdl-28291630
ABSTRACT
Ceftriaxone is a cephalosporin antibiotic with a potent antimicrobial activity and excellent penetration in most body fluids such as pleural, peritoneal, spinal and brain. These facts contribute to the application of ceftriaxone in the treatment of bacterial peritonitis, an abdominal disorder in veterinary medicine, with potential risk of death. The determination of ceftriaxone levels in plasma and peritoneal fluid may be used to assess the pharmacokinetic profile at various instances of administration and allows observing if the concentrations needed are being achieved. Therefore a method was developed and validated for the determination of ceftriaxone in plasma and peritoneal fluid which after was applied in a pharmacokinetic profile study. The bioanalytical method validation was performed according to widely acceptable experiments. Two horses were used as a model of the method applicability; ceftriaxone was intraperitoneally administered to these animals as a single dose. The plasma and peritoneal fluid analysis were performed using an UHPLC system in reverse phase chromatography mode in fully validated conditions. The methods have shown linearity between 0.49 and 500µg/mL for plasma, and between 0.24 and 500µg/mL for peritoneal fluid. The quantitative analysis of ceftriaxone in these matrices allows monitoring of the therapy. This method showed improved sensitivity as well as the quantitation in peritoneal fluid.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasma / Ceftriaxona / Líquido Ascítico / Cromatografia Líquida / Antibacterianos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Plasma / Ceftriaxona / Líquido Ascítico / Cromatografia Líquida / Antibacterianos Idioma: En Ano de publicação: 2017 Tipo de documento: Article